Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph I Helman

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Cancer Research|November 25, 2010
Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cellsSudha Krishnamurthy, Zhihong Dong, Dmitry Vodopyanov, et al.
Sleep Medicine|May 15, 2010
MRI of the pharynx in ischemic stroke patients with and without obstructive sleep apneaDevin L Brown, J Rajiv Bapuraj, Suresh K Mukherji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2016
Therapeutic Inhibition of the MDM2-p53 Interaction Prevents Recurrence of Adenoid Cystic CarcinomasFelipe Nör, Kristy A Warner, Zhaocheng Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2018
Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2-p53 Interaction in Mucoepidermoid CarcinomaApril Andrews, Kristy Warner, Christie Rodriguez-Ramirez, et al.
Head & Neck|August 22, 2012
Effect of erlotinib on epidermal growth factor receptor and downstream signaling in oral cavity squamous cell carcinomaChristina I Tsien, Mukesh K Nyati, Aarif Ahsan, et al.
Stem Cells (Dayton, Ohio)|August 1, 2014
Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cellsSudha Krishnamurthy, Kristy A Warner, Zhihong Dong, et al.
BMC Cancer|November 1, 2015
NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomasShama Virani, Emily Bellile, Carol R Bradford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Pilot randomized phase II study of celecoxib in oral premalignant lesionsVassiliki A Papadimitrakopoulou, William N William, Andrew J Dannenberg, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Cancer Research|November 25, 2010
Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cellsSudha Krishnamurthy, Zhihong Dong, Dmitry Vodopyanov, et al.
Sleep Medicine|May 15, 2010
MRI of the pharynx in ischemic stroke patients with and without obstructive sleep apneaDevin L Brown, J Rajiv Bapuraj, Suresh K Mukherji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2016
Therapeutic Inhibition of the MDM2-p53 Interaction Prevents Recurrence of Adenoid Cystic CarcinomasFelipe Nör, Kristy A Warner, Zhaocheng Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2018
Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2-p53 Interaction in Mucoepidermoid CarcinomaApril Andrews, Kristy Warner, Christie Rodriguez-Ramirez, et al.
Head & Neck|August 22, 2012
Effect of erlotinib on epidermal growth factor receptor and downstream signaling in oral cavity squamous cell carcinomaChristina I Tsien, Mukesh K Nyati, Aarif Ahsan, et al.
Stem Cells (Dayton, Ohio)|August 1, 2014
Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cellsSudha Krishnamurthy, Kristy A Warner, Zhihong Dong, et al.
BMC Cancer|November 1, 2015
NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomasShama Virani, Emily Bellile, Carol R Bradford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Pilot randomized phase II study of celecoxib in oral premalignant lesionsVassiliki A Papadimitrakopoulou, William N William, Andrew J Dannenberg, et al.
Pageof 4